Fate Therapeutics
(FATE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FATE | CBIO | ELDN | ||
| Company | Fate Therapeutics | Crescent Biopharma Inc | Eledon Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.1300 | 9.51 | 2.19 | ||
| High | 1.1300 | 9.62 | 2.22 | ||
| Low | 1.0700 | 8.72 | 2.08 | ||
| Latest | 1.1200 | 9.45 | 2.13 | ||
| Change | -0.0200 | -0.06 | -0.06 | ||
| % Change | -1.75% | -0.63% | -2.74% | ||
| Volume | 957,700 | 299,500 | 339,900 | ||
| 20-Day Average Volume | 1,786,525 | 221,870 | 645,780 | ||
| Previous Close | 1.1400 | 9.51 | 2.19 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.1565 | 11.29 | 2.13 | ||
| 20-Day Raw Stochastic | 33.33% | 12.19% | 68.25% | ||
| 20-Day Relative Strength | 49.56 | 36.29 | 53.56 | ||
| Weighted Alpha | -37.64 | -65.76 | -17.13 | ||
| Today's Opinion | 48% Sell | 100% Sell | 48% Sell | ||
| Previous Opinion | 32% Sell | 100% Sell | 40% Sell | ||
| Last Month's Opinion | 64% Sell | 88% Sell | 80% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.94% since 02/02/26 | -3.77% since 02/02/26 | -6.58% since 02/02/26 | ||
| Low | 1.0400 on 02/05/26 | 8.72 on 02/09/26 | 1.96 on 02/05/26 | ||
| High | 1.2300 on 02/03/26 | 10.00 on 02/03/26 | 2.32 on 02/03/26 | ||
| 1-Month | |||||
| %Chg | +6.67% since 01/09/26 | -12.42% since 01/09/26 | +23.12% since 01/09/26 | ||
| Low | 1.0200 on 01/13/26 | 8.72 on 02/09/26 | 1.70 on 01/13/26 | ||
| High | 1.3200 on 01/28/26 | 14.71 on 01/21/26 | 2.33 on 02/02/26 | ||
| 3-Month | |||||
| %Chg | +4.67% since 11/07/25 | -28.03% since 11/07/25 | +3.40% since 11/07/25 | ||
| Low | 0.9500 on 11/14/25 | 8.72 on 02/09/26 | 1.35 on 11/21/25 | ||
| High | 1.3200 on 01/28/26 | 16.35 on 12/04/25 | 2.40 on 11/10/25 | ||
| 6-Month | |||||
| %Chg | +21.55% since 08/08/25 | -26.46% since 08/08/25 | -21.55% since 08/08/25 | ||
| Low | 0.9100 on 08/11/25 | 8.72 on 02/09/26 | 1.35 on 11/21/25 | ||
| High | 1.9399 on 10/27/25 | 16.35 on 12/04/25 | 4.60 on 11/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 131,501 | 132,122 | 131,251 | ||
| Shares Outstanding, K | 115,352 | 13,893 | 59,932 | ||
| Annual Sales | 13,630,000 | 794,000 | 0 | ||
| Annual Net Income | -186,260,000 | -37,880,000 | -36,180,000 | ||
| Last Quarter Sales | 1,740,000 | 0 | 0 | ||
| Last Quarter Net Income | -32,250,000 | -24,610,000 | -17,460,000 | ||
| 60-Month Beta | 2.24 | 1.35 | 0.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 11/13/25 | -1.27 on 11/06/25 | -0.21 on 11/14/25 | ||
| Latest Earnings Date | 03/04/26 | 02/12/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 08/20/15 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||